Ambarella, Inc. (NASDAQ:AMBA – Get Free Report) VP Christopher Day sold 483 shares of the company’s stock in a transaction dated Tuesday, September 17th. The shares were sold at an average price of $53.54, for a total transaction of $25,859.82. Following the transaction, the vice president now owns 21,370 shares in the company, valued at […]

Ambarella, Inc. (NASDAQ:AMBA – Get Free Report) CTO Leslie Kohn sold 1,608 shares of the business’s stock in a transaction that occurred on Tuesday, September 17th. The shares were sold at an average price of $53.54, for a total value of $86,092.32. Following the transaction, the chief technology officer now owns 961,433 shares of the […]

Natera, Inc. (NASDAQ:NTRA – Get Free Report) CEO Steven Leonard Chapman sold 5,024 shares of the company’s stock in a transaction dated Monday, September 16th. The stock was sold at an average price of $128.48, for a total transaction of $645,483.52. Following the transaction, the chief executive officer now owns 195,686 shares in the company, […]

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) insider Oxana Beskrovnaya sold 2,339 shares of the firm’s stock in a transaction dated Wednesday, September 18th. The stock was sold at an average price of $34.55, for a total value of $80,812.45. Following the completion of the transaction, the insider now owns 140,375 shares of the […]

EverCommerce Inc. (NASDAQ:EVCM – Get Free Report) CEO Eric Richard Remer sold 10,311 shares of the company’s stock in a transaction dated Tuesday, September 17th. The stock was sold at an average price of $10.69, for a total value of $110,224.59. Following the sale, the chief executive officer now owns 8,138,352 shares in the company, […]

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) COO Susanna Gatti High sold 8,976 shares of Dyne Therapeutics stock in a transaction dated Wednesday, September 18th. The shares were sold at an average price of $34.41, for a total transaction of $308,864.16. Following the completion of the sale, the chief operating officer now owns 131,636 […]

Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) insider Robert A. Lenz sold 30,788 shares of the business’s stock in a transaction that occurred on Tuesday, September 17th. The stock was sold at an average price of $11.81, for a total value of $363,606.28. Following the sale, the insider now directly owns 339,205 shares in […]

T. Rowe Price Group, Inc. (NASDAQ:TROW – Get Free Report) insider Jessica M. Hiebler sold 484 shares of the company’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $104.73, for a total transaction of $50,689.32. Following the sale, the insider now directly owns 13,939 shares of […]